Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma Academic Article uri icon

Overview

MeSH Major

  • Antimetabolites, Antineoplastic
  • Carcinoma, Transitional Cell
  • Glutamates
  • Guanine
  • Pelvic Neoplasms
  • Salvage Therapy
  • Urethral Neoplasms
  • Urinary Bladder Neoplasms
  • Urothelium

abstract

  • Pemetrexed as second-line therapy in advanced urothelial carcinoma is associated with modest activity. The role of this novel antifolate in chemotherapy-na├»ve patients warrants further investigation.

publication date

  • June 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1007/s10637-006-9020-9

PubMed ID

  • 17146733

Additional Document Info

start page

  • 265

end page

  • 70

volume

  • 25

number

  • 3